179 related articles for article (PubMed ID: 11996792)
1. Elevated frequency of ATM gene missense mutations in breast cancer relative to ethnically matched controls.
Sommer SS; Buzin CH; Jung M; Zheng J; Liu Q; Jeong SJ; Moulds J; Nguyen VQ; Feng J; Bennett WP; Dritschilo A
Cancer Genet Cytogenet; 2002 Apr; 134(1):25-32. PubMed ID: 11996792
[TBL] [Abstract][Full Text] [Related]
2. ATM missense mutations are frequent in patients with breast cancer.
Sommer SS; Jiang Z; Feng J; Buzin CH; Zheng J; Longmate J; Jung M; Moulds J; Dritschilo A
Cancer Genet Cytogenet; 2003 Sep; 145(2):115-20. PubMed ID: 12935922
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive scanning of the ATM gene with DOVAM-S.
Buzin CH; Gatti RA; Nguyen VQ; Wen CY; Mitui M; Sanal O; Chen JS; Nozari G; Mengos A; Li X; Fujimura F; Sommer SS
Hum Mutat; 2003 Feb; 21(2):123-31. PubMed ID: 12552559
[TBL] [Abstract][Full Text] [Related]
4. Involvement of ATM missense variants and mutations in a series of unselected breast cancer cases.
Rodriguez C; Vallès H; Causse A; Johannsdottir V; Eliaou JF; Theillet C
Genes Chromosomes Cancer; 2002 Feb; 33(2):141-9. PubMed ID: 11793440
[TBL] [Abstract][Full Text] [Related]
5. Absence of somatic ATM missense mutations in 58 mammary carcinomas.
Feng J; Yan J; Chen J; Schlake G; Jiang Z; Buzin CH; Sommer SS; Dritschilo A
Cancer Genet Cytogenet; 2003 Sep; 145(2):179-82. PubMed ID: 12935933
[TBL] [Abstract][Full Text] [Related]
6. Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer.
Tavtigian SV; Oefner PJ; Babikyan D; Hartmann A; Healey S; Le Calvez-Kelm F; Lesueur F; Byrnes GB; Chuang SC; Forey N; Feuchtinger C; Gioia L; Hall J; Hashibe M; Herte B; McKay-Chopin S; Thomas A; Vallée MP; Voegele C; Webb PM; Whiteman DC; ; ; ; Sangrajrang S; Hopper JL; Southey MC; Andrulis IL; John EM; Chenevix-Trench G
Am J Hum Genet; 2009 Oct; 85(4):427-46. PubMed ID: 19781682
[TBL] [Abstract][Full Text] [Related]
7. Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients.
Dörk T; Bendix R; Bremer M; Rades D; Klöpper K; Nicke M; Skawran B; Hector A; Yamini P; Steinmann D; Weise S; Stuhrmann M; Karstens JH
Cancer Res; 2001 Oct; 61(20):7608-15. PubMed ID: 11606401
[TBL] [Abstract][Full Text] [Related]
8. Missense mutations but not allelic variants alter the function of ATM by dominant interference in patients with breast cancer.
Scott SP; Bendix R; Chen P; Clark R; Dork T; Lavin MF
Proc Natl Acad Sci U S A; 2002 Jan; 99(2):925-30. PubMed ID: 11805335
[TBL] [Abstract][Full Text] [Related]
9. Increased frequency of ATM mutations in breast carcinoma patients with early onset disease and positive family history.
Teraoka SN; Malone KE; Doody DR; Suter NM; Ostrander EA; Daling JR; Concannon P
Cancer; 2001 Aug; 92(3):479-87. PubMed ID: 11505391
[TBL] [Abstract][Full Text] [Related]
10. Contribution of mutations in ATM to breast cancer development in the Czech population.
Soukupova J; Dundr P; Kleibl Z; Pohlreich P
Oncol Rep; 2008 Jun; 19(6):1505-10. PubMed ID: 18497957
[TBL] [Abstract][Full Text] [Related]
11. ATM germline mutations in women with familial breast cancer and a relative with haematological malignancy.
Paglia LL; Laugé A; Weber J; Champ J; Cavaciuti E; Russo A; Viovy JL; Stoppa-Lyonnet D
Breast Cancer Res Treat; 2010 Jan; 119(2):443-52. PubMed ID: 19404735
[TBL] [Abstract][Full Text] [Related]
12. Common ataxia telangiectasia mutated haplotypes and risk of breast cancer: a nested case-control study.
Tamimi RM; Hankinson SE; Spiegelman D; Kraft P; Colditz GA; Hunter DJ
Breast Cancer Res; 2004; 6(4):R416-22. PubMed ID: 15217510
[TBL] [Abstract][Full Text] [Related]
13. The relationship between twenty missense ATM variants and breast cancer risk: the Multiethnic Cohort.
Bretsky P; Haiman CA; Gilad S; Yahalom J; Grossman A; Paglin S; Van Den Berg D; Kolonel LN; Skaliter R; Henderson BE
Cancer Epidemiol Biomarkers Prev; 2003 Aug; 12(8):733-8. PubMed ID: 12917204
[TBL] [Abstract][Full Text] [Related]
14. Screening for ATM sequence alterations in African-American women diagnosed with breast cancer.
Hirsch AE; Atencio DP; Rosenstein BS
Breast Cancer Res Treat; 2008 Jan; 107(1):139-44. PubMed ID: 17333338
[TBL] [Abstract][Full Text] [Related]
15. Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls.
Fletcher O; Johnson N; dos Santos Silva I; Orr N; Ashworth A; Nevanlinna H; Heikkinen T; Aittomäki K; Blomqvist C; Burwinkel B; Bartram CR; Meindl A; Schmutzler RK; Cox A; Brock I; Elliott G; Reed MW; Southey MC; Smith L; Spurdle AB; Hopper JL; Couch FJ; Olson JE; Wang X; Fredericksen Z; Schürmann P; Waltes R; Bremer M; Dörk T; Devilee P; van Asperen CJ; Tollenaar RA; Seynaeve C; Hall P; Czene K; Humphreys K; Liu J; Ahmed S; Dunning AM; Maranian M; Pharoah PD; Chenevix-Trench G; ; ; Beesley J; Bogdanova NV; Antonenkova NN; Zalutsky IV; Anton-Culver H; Ziogas A; Brauch H; Ko YD; Hamann U; ; Fasching PA; Strick R; Ekici AB; Beckmann MW; Giles GG; Severi G; Baglietto L; English DR; Milne RL; Benítez J; Arias JI; Pita G; Nordestgaard BG; Bojesen SE; Flyger H; Kang D; Yoo KY; Noh DY; Mannermaa A; Kataja V; Kosma VM; García-Closas M; Chanock S; Lissowska J; Brinton LA; Chang-Claude J; Wang-Gohrke S; Broeks A; Schmidt MK; van Leeuwen FE; Van't Veer LJ; Margolin S; Lindblom A; Humphreys MK; Morrison J; Platte R; Easton DF; Peto J;
Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2143-51. PubMed ID: 20826828
[TBL] [Abstract][Full Text] [Related]
16. Cancer risk according to type and location of ATM mutation in ataxia-telangiectasia families.
Cavaciuti E; Laugé A; Janin N; Ossian K; Hall J; Stoppa-Lyonnet D; Andrieu N
Genes Chromosomes Cancer; 2005 Jan; 42(1):1-9. PubMed ID: 15390180
[TBL] [Abstract][Full Text] [Related]
17. Ataxia-telangiectasia genes and breast cancer risk in a French family study.
Andrieu N; Cavaciuti E; Laugé A; Ossian K; Janin N; Hall J; Stoppa-Lyonnet D
J Dairy Res; 2005; 72 Spec No():73-80. PubMed ID: 16180724
[TBL] [Abstract][Full Text] [Related]
18. Dominant negative ATM mutations in breast cancer families.
Chenevix-Trench G; Spurdle AB; Gatei M; Kelly H; Marsh A; Chen X; Donn K; Cummings M; Nyholt D; Jenkins MA; Scott C; Pupo GM; Dörk T; Bendix R; Kirk J; Tucker K; McCredie MR; Hopper JL; Sambrook J; Mann GJ; Khanna KK
J Natl Cancer Inst; 2002 Feb; 94(3):205-15. PubMed ID: 11830610
[TBL] [Abstract][Full Text] [Related]
19. ATM-heterozygous germline mutations contribute to breast cancer-susceptibility.
Broeks A; Urbanus JH; Floore AN; Dahler EC; Klijn JG; Rutgers EJ; Devilee P; Russell NS; van Leeuwen FE; van 't Veer LJ
Am J Hum Genet; 2000 Feb; 66(2):494-500. PubMed ID: 10677309
[TBL] [Abstract][Full Text] [Related]
20. ATM mutations in female breast cancer patients predict for an increase in radiation-induced late effects.
Iannuzzi CM; Atencio DP; Green S; Stock RG; Rosenstein BS
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):606-13. PubMed ID: 11849780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
